www.braintumourhub.org.uk / Search results

Registered Charity No 1114634

Relates to tumour types	Title of Research	Description	More information
Schwannoma Pituitary Paediatric Brain metastases Neuroblastoma oligoastrocytoma Ependymoma Meningioma Medulloblastoma Glioma Glioblastoma Astrocytoma Anaplastic oligodendroglioma Anaplastic glioma Anaplastic astrocytoma	VoxTox - Linking radiation dose at the voxel level with toxicity (Study ID: 13716)	An observational study to collect detailed information about side effects for patients undergoing image-guided intensity-modulated radiotherapy to the head and neck,... read more	Click for more details and contact information
Schwannoma Pituitary Paediatric Neuroblastoma oligoastrocytoma Ependymoma Meningioma Medulloblastoma Glioma Astrocytoma	MOT – Identification and validating molecular targets in low grade brain tumours (Study ID: 16948)	A laboratory study using surplus tissue from all low grade brain tumours to discover and validate new molecular drug targets. read more	Click for more details and contact information
Schwannoma Pituitary Brain metastases Neuroblastoma oligoastrocytoma Ependymoma Meningioma Medulloblastoma Glioma Glioblastoma Astrocytoma Anaplastic oligodendroglioma Anaplastic glioma Anaplastic astrocytoma	Wrist Worn Trackers for monitoring physical activity in brain tumour patients (Study ID: 38629)	Most patient with brain tumours develop functional disturbance (weakness, balance problems, etc.) as part of their illness, and report fatigue as being a significant... read more	Click for more details and contact information
Schwannoma Pituitary Brain metastases Neuroblastoma oligoastrocytoma Ependymoma Meningioma Medulloblastoma Glioma Glioblastoma Astrocytoma Anaplastic oligodendroglioma Anaplastic glioma Anaplastic astrocytoma	MOLGEN – Molecular Genetics of Adverse Drug Reactions (Study ID: 8630)	Adverse drug reactions (ADR's) are a common cause of drug-related morbidity and may account for about 6.5% of all hospital admissions. A meta-analysis of studies... read more	Click for more details and contact information
Schwannoma Pituitary Brain metastases Neuroblastoma oligoastrocytoma Ependymoma Meningioma Medulloblastoma Glioma Glioblastoma Astrocytoma Anaplastic oligodendroglioma Anaplastic glioma Anaplastic astrocytoma	Establishing multipotent stem cell lines from CNS tumours (Study ID: 32706)	A striking feature of some central nervous system (CNS) tumours is the presence of cell types indicative of mixed neural/glial and mesodermal/mesenchymal (e.g.... read more	Click for more details and contact information
Anaplastic astrocytoma Anaplastic glioma Anaplastic oligodendroglioma Astrocytoma Glioblastoma Glioma Medulloblastoma Meningioma Ependymoma oligoastrocytoma Neuroblastoma Brain metastases Pituitary Schwannoma	Hyperpolarised 13C-Pyruvate MRI study (Study ID: 34177)	Metabolic changes related to disease are the precursor to anatomical changes in tissues. Currently our imaging methods routinely used in clinical practice look at the... read more	Click for more details and contact information
Anaplastic astrocytoma Anaplastic glioma Anaplastic oligodendroglioma Astrocytoma Glioblastoma Glioma Medulloblastoma Meningioma Ependymoma oligoastrocytoma Neuroblastoma Brain metastases Pituitary Schwannoma	Identifying the origin of circulating DNA to detect and diagnose neuro (Study ID: 36279)	Damaged and dying cells release DNA into the circulation. This circulating, cell-free DNA (cfDNA) can be easily detected in blood and other bodily fluids such as... read more	Click for more details and contact information
Anaplastic astrocytoma Anaplastic glioma Anaplastic oligodendroglioma Astrocytoma Glioblastoma Glioma Medulloblastoma Meningioma Ependymoma oligoastrocytoma Neuroblastoma Brain metastases Pituitary Schwannoma	Harnessing plasticity to treat brain tumours (Study ID: 37315)	Brain tumours are hard to treat. They are not very sensitive to chemotherapy and radiotherapy. The main therapy is brain surgery to remove the tumour. Even if the... read more	Click for more details and contact information
Anaplastic astrocytoma Anaplastic glioma Anaplastic oligodendroglioma Astrocytoma Glioblastoma Glioma Medulloblastoma Meningioma Ependymoma oligoastrocytoma Neuroblastoma Brain metastases Pituitary Schwannoma	HSI Neuro Phantom (Study ID: 38815)	Successful neurosurgery to remove brain tumours depends on achieving maximal safe tumour removal; avoiding damaging sensitive areas that undertake vital functions and... read more	Click for more details and contact information
Schwannoma Pituitary Brain metastases Neuroblastoma oligoastrocytoma Ependymoma Meningioma Medulloblastoma Glioma Glioblastoma Astrocytoma Anaplastic oligodendroglioma Anaplastic glioma Anaplastic astrocytoma	BT-LIFE – Brain Tumours, Lifestyle Interventions, and Fatigue Evaluations (Study ID: 38936)	'BT-LIFE' stands for “Brain Tumours, Lifestyle Interventions, and Fatigue Evaluation." We aim to see if it is feasible to treat fatigue without using drugs, in... read more	Click for more details and contact information
Paediatric Medulloblastoma	PNET 5 (Study ID: 31891)	The PNET 5 study has been designed for children and young people aged from 3 yrs to 22 yrs with standard risk medulloblastoma who have undergone surgery to remove... read more	Click for more details and contact information

View by brain tumour type: All brain tumour types , Anaplastic astrocytoma, Anaplastic glioma, Anaplastic oligodendroglioma, Astrocytoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Ependymoma, oligoastrocytoma, Neuroblastoma, Brain metastases, Paediatric, Pituitary, Schwannoma

© 2024 brainstrust | Contact us | Click here to add a brain tumour support service Click here to add a brain tumour clinical trial
Registered Charity No 1114634

            The Vera Wolstencroft Children And Animal Charitable Trust'

Think Creative